tributyrin has been researched along with Experimental Hepatoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, FO; Farsky, SHP; Fernandes, LHG; Furtado, KS; Hebeda, CB; Heidor, R; Horst, MA; Miranda, MLP; Moreno, FS; Sandri, S; Yamamoto, RC | 1 |
Beland, FA; de Conti, A; Heidor, R; Koturbash, I; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Pogribny, IP; Tryndyak, V | 1 |
de Conti, A; de Paiva, SA; Furtado, KS; Gioielli, LA; Heidor, R; Moreno, FS; Ortega, JF; Pogribny, IP; Purgatto, E; Ract, JN; Silva, RC; Tavares, PE | 1 |
de Conti, A; Horst, MA; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Pereira, D; Purgatto, E; Scolastici, C | 1 |
Bassoli, BK; Camargo, AA; Cavalher, FP; Chagas, CE; de Conti, A; Horst, MA; Jordão, AA; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Purgatto, E; Scolastici, C; Vannucchi, H | 1 |
5 other study(ies) available for tributyrin and Experimental Hepatoma
Article | Year |
---|---|
Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis.
Topics: Actins; Angiogenesis Inhibitors; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Gene Expression Regulation, Neoplastic; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Polysaccharides; Prodrugs; Rats; Triglycerides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
Topics: Acetylation; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Hepatocytes; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Liver Neoplasms, Experimental; Lysine; Male; Precancerous Conditions; Prodrugs; Random Allocation; Rats; Rats, Wistar; Signal Transduction; Triglycerides; Tumor Suppressor Protein p53; Up-Regulation | 2013 |
The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Butyric Acid; Gene Expression Regulation; Histones; Linseed Oil; Lipids; Liver Neoplasms, Experimental; Male; Oncogenes; Precancerous Conditions; Rats, Wistar; Triglycerides | 2016 |
Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug.
Topics: Acetylation; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Liver; Liver Neoplasms, Experimental; Male; Prodrugs; Rats; Rats, Wistar; Triglycerides; Tumor Suppressor Protein p53 | 2009 |
Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Chemoprevention; Hepatocytes; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Wistar; rho GTP-Binding Proteins; Triglycerides; Vitamin A | 2012 |